project id: TCGA-KIRC; case submitter id: TCGA-DV-A4W0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 55; days to birth: -20101; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1953; age at diagnosis: 20101; ajcc clinical m: M0; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2470.0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8310/3; primary diagnosis: Clear cell adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: Yes; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.8082191780821917; pack years smoked: 33.0; is ffpe: false; composition: Not Reported; days to collection: 1681; days to sample procurement: 0; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent tumor nuclei: 90.0;